Schulte J M, Schmid G P
Epidemiology Research Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
Clin Infect Dis. 1995 Apr;20 Suppl 1:S39-46. doi: 10.1093/clinids/20.supplement_1.s39.
Since the 1989 Sexually Transmitted Diseases Treatment Guidelines were published by the Centers for Disease Control and Prevention, changes in the efficacy of the recommended and alternative regimens for the treatment of Haemophilus ducreyi infections have been described. Among recommended agents, erythromycin remains effective, and although a single dose of ceftriaxone appears to remain effective in the United States, limited data from Kenya have shown that this regimen has been associated with treatment failures. Of alternative treatment regimens, trimethoprim-sulfamethoxazole has been associated with widespread failure, but little work has been done to further evaluate the efficacy of the amoxicillin/clavulanic acid and ciprofloxacin regimens. Of the new antimicrobials, azithromycin has been very effective in the United States, but the efficacy of this drug elsewhere has not been thoroughly evaluated. Fleroxacin has been very effective in Kenya. Data from Africa indicate that patients who are infected with the human immunodeficiency virus do not respond to therapy as well as patients who are not, and patients who are uncircumcised may not respond as well to therapy as do patients who are circumcised.
自美国疾病控制与预防中心于1989年发布《性传播疾病治疗指南》以来,已报道了治疗杜克雷嗜血杆菌感染的推荐方案和替代方案在疗效方面的变化。在推荐药物中,红霉素仍然有效,虽然单剂量头孢曲松在美国似乎仍然有效,但来自肯尼亚的有限数据表明,该方案与治疗失败有关。在替代治疗方案中,甲氧苄啶-磺胺甲恶唑已与广泛的治疗失败相关,但在进一步评估阿莫西林/克拉维酸和环丙沙星方案的疗效方面几乎没有开展工作。在新型抗菌药物中,阿奇霉素在美国非常有效,但该药物在其他地方的疗效尚未得到充分评估。氟罗沙星在肯尼亚非常有效。来自非洲的数据表明,感染人类免疫缺陷病毒的患者对治疗的反应不如未感染的患者,未行包皮环切术的患者对治疗的反应可能不如行包皮环切术的患者。